Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
2002 1
2003 7
2004 7
2005 9
2006 3
2007 5
2008 3
2009 11
2010 6
2011 11
2012 20
2013 16
2014 13
2015 10
2016 20
2017 20
2018 18
2019 27
2020 30
2021 14
Text availability
Article attribute
Article type
Publication date

Search Results

217 results
Results by year
Filters applied: . Clear all
Page 1
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper.
Abdul-Aziz MH, Alffenaar JC, Bassetti M, Bracht H, Dimopoulos G, Marriott D, Neely MN, Paiva JA, Pea F, Sjovall F, Timsit JF, Udy AA, Wicha SG, Zeitlinger M, De Waele JJ, Roberts JA; Infection Section of European Society of Intensive Care Medicine (ESICM); Pharmacokinetic/pharmacodynamic and Critically Ill Patient Study Groups of European Society of Clinical Microbiology and Infectious Diseases (ESCMID); Infectious Diseases Group of International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT); Infections in the ICU and Sepsis Working Group of International Society of Antimicrobial Chemotherapy (ISAC). Abdul-Aziz MH, et al. Among authors: zeitlinger m. Intensive Care Med. 2020 Jun;46(6):1127-1153. doi: 10.1007/s00134-020-06050-1. Epub 2020 May 7. Intensive Care Med. 2020. PMID: 32383061 Free PMC article. Review.
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial.
Wunderink RG, Matsunaga Y, Ariyasu M, Clevenbergh P, Echols R, Kaye KS, Kollef M, Menon A, Pogue JM, Shorr AF, Timsit JF, Zeitlinger M, Nagata TD. Wunderink RG, et al. Among authors: zeitlinger m. Lancet Infect Dis. 2021 Feb;21(2):213-225. doi: 10.1016/S1473-3099(20)30731-3. Epub 2020 Oct 12. Lancet Infect Dis. 2021. PMID: 33058798 Clinical Trial.
Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents.
Zeitlinger M, Koch BCP, Bruggemann R, De Cock P, Felton T, Hites M, Le J, Luque S, MacGowan AP, Marriott DJE, Muller AE, Nadrah K, Paterson DL, Standing JF, Telles JP, Wölfl-Duchek M, Thy M, Roberts JA; PK/PD of Anti-Infectives Study Group (EPASG) of the European Society of Clinical Microbiology, Infectious Diseases (ESCMID). Zeitlinger M, et al. Clin Pharmacokinet. 2020 Oct;59(10):1195-1216. doi: 10.1007/s40262-020-00924-9. Clin Pharmacokinet. 2020. PMID: 32725382 Free PMC article.
Phosphorylation Control of p53 DNA-Binding Cooperativity Balances Tumorigenesis and Aging.
Timofeev O, Koch L, Niederau C, Tscherne A, Schneikert J, Klimovich M, Elmshäuser S, Zeitlinger M, Mernberger M, Nist A, Osterburg C, Dötsch V, Hrabé de Angelis M, Stiewe T; German Mouse Clinic Consortium. Timofeev O, et al. Among authors: zeitlinger m. Cancer Res. 2020 Dec 1;80(23):5231-5244. doi: 10.1158/0008-5472.CAN-20-2002. Epub 2020 Sep 1. Cancer Res. 2020. PMID: 32873634
PCSK9 decreases during experimental endotoxemia.
Schoergenhofer C, Matzneller P, Mühlbacher J, Hell L, Zeitlinger M, Jilma B. Schoergenhofer C, et al. Among authors: zeitlinger m. J Intern Med. 2020 Mar;287(3):333-335. doi: 10.1111/joim.13003. Epub 2019 Nov 14. J Intern Med. 2020. PMID: 31660669 No abstract available.
A pragmatic trial in bone and joint infection.
Zeitlinger M. Zeitlinger M. Lancet Infect Dis. 2019 Aug;19(8):804-805. doi: 10.1016/S1473-3099(19)30354-8. Lancet Infect Dis. 2019. PMID: 31345447 Clinical Trial. No abstract available.
217 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page